Sorted By:

Relevance


GAO: Prescription Drugs Are Just 2% of Medicaid Spending

PhRMA  |  Blog Post


http://catalyst.phrma.org/gao-prescription-drugs-are-just-2-percent-of-medicaid-spending

PhRMA Statement on AARP Prescription Drug Report

PhRMA  |  Press Release

We will continue to be a constructive partner to help pass a comprehensive health care reform bill that can get to the President’s desk this year.”
https://www.phrma.org/press-release/phrma-statement-on-aarp-prescription-drug-report

Medicare Part D Savings

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicare-part-d-savings

Paving the Way for Better Cancer Treatments

PhRMA  |  Blog Post


http://catalyst.phrma.org/paving-the-way-for-better-cancer-treatments

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

PhRMA  |  Blog Post

Learn more about Medicare Part D and the importance of ensuring the program continues to provide seniors and individuals with disabilities access to affordable prescription drug coverage.
http://catalyst.phrma.org/medicare-monday-how-government-price-setting-in-part-d-could-reduce-innovation-shorten-life-expectancy-for-beneficiaries

New Medicines - the Long Path to Approval

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-medicines-the-long-path-to-approval

World AIDS Day: Making progress

PhRMA  |  Blog Post

While medication can help keep HIV from becoming AIDS, one has to first know they are infected which is why it can be surprising that 156,000 of those infected with HIV don’t even know they have it.
http://catalyst.phrma.org/world-aids-day-2015

Medicare Monday: PhRMA's comments on new direction for CMMI

PhRMA  |  Blog Post

That’s why we encourage the Administration to review all of the feedback provided by stakeholders as part of this RFI process before issuing any new demos.
http://catalyst.phrma.org/medicare-monday-phrmas-comments-on-new-direction-for-cmmi

Part B

PhRMA  |  From PhRMA

Recent research found the volume-weighted average sales price for Part B drugs has remained steady year over year, suggesting that prescription medicines and biologicals are not a key driver of program costs.
https://www.phrma.org/advocacy/medicare/partb

MIT scientists find evidence that Alzheimer’s ‘lost memories’ may one day be recoverable

From Hope To Cures  |  From Our Network

 Nature reported that early trials showed that deep-brain stimulation of the hippocampus may improve memory in some Alzheimer's patients.
http://www.fromhopetocures.org/mit-scientists-find-evidence-that-alzheimer-s-lost-memories-may-one-day-be-recoverable

A Day In The Life

PhRMA  |  From PhRMA

Learn more about some of our biopharmaceutical scientists themselves, about their day-to-day lives and how they are inspiring the next generation of biopharmaceutical scientists.
https://www.phrma.org/media/a-day-in-the-life

New Blood Tests, Liquid Biopsies, May Transform Cancer Care

From Hope To Cures  |  From Our Network

Still, patients do better when drugs are matched to their tumors, and liquid biopsies may give a practical way to do that more often.
http://www.fromhopetocures.org/new-blood-tests-liquid-biopsies-may-transform-cancer-care

Medicare Monday: A guide to MedPAC’s Part B vote this week

PhRMA  |  Blog Post

The ASP mechanism has been successful at moderating price growth over time, and even CMS has noted multiple competitive factors are at work to keep prices stable.
http://catalyst.phrma.org/medicare-monday-a-guide-to-medpacs-part-b-vote-this-week

Critics Say High Deductibles Make Insurance ‘Unaffordable’

Access Better Coverage  |  From Our Network

The mounting debt has Roger Anderson choosing to forgo the twice-weekly physical therapy prescribed by his doctor — and losing muscle mass as a consequence — because he can’t afford the $200-a-month copay.
http://www.accessbettercoverage.org/social-news/critics-say-high-deductibles-make-insurance-unaffordable

Biopharmaceutical Sector Leads the Way in Clinical Trial Data Sharing

PhRMA  |  Blog Post


http://catalyst.phrma.org/biopharmaceutical-sector-leads-the-way-in-clinical-trial-data-sharing

New Chart Pack: Advancing Innovative Treatment Options for Patients Through Personalized Medicine

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-chart-pack-advancing-innovative-treatment-options-for-patients-through-personalized-medicine

The War on Alzheimer’s: Progress and Challenges of Biopharmaceutical Research

PhRMA  |  Blog Post

While researchers have come a long way, we still have much work to do to understand causes of the disease and how it progresses.
http://catalyst.phrma.org/the-war-on-alzheimers-progress-and-challenges-of-biopharmaceutical-research

Biopharmaceuticals in Perspective: Chart Pack 2013

PhRMA  |  Report

Topics include medicines’ impact on health and quality of life, the drug discovery and development process, biopharmaceutical spending and costs, the challenge of treatment gaps and improving use of prescribed therapies, the marketing and promotion of medicines, and the role of the biopharmaceutical sector in the U.S. economy.
https://www.phrma.org/report/biopharmaceuticals-in-perspective-chart-pack-2013

Because One Day Isn't Enough

PhRMA  |  Blog Post

Click here to see some videos that we put together about rare diseases and come back throughout the week to see what else has caught our eyes.
http://catalyst.phrma.org/because-one-day-isnt-enough

2016 BCI Survey: A pro-innovation environment is essential for biopharmaceutical investment

PhRMA  |  Blog Post

Though some important gaps exist around market access policies and patent enforcement, in most respects top scoring economies are viewed as having IP environments in line with international standards and supporting biopharmaceutical innovation and technology transfer through positive incentives and dedicated funding.
http://catalyst.phrma.org/2016-bci-survey-a-pro-innovation-environment-is-essential-for-biopharmaceutical-investment

A new kind of Chart Pack

PhRMA  |  Blog Post

Please share the Chart Pack platform with your network, and stay tuned for updates and additions!
http://catalyst.phrma.org/a-new-kind-of-chart-pack

Medicare Monday: Managing Diabetes Thanks to Medicare Part D

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicare-monday-managing-diabetes-thanks-to-medicare-part-d

Burden on Patients: Mental Health Disorders Can Affect Anyone and Health Insurance Exchanges Must Provide Needed Medicines

PhRMA  |  Blog Post

Research shows that the more an individual must pay for medicines, the more likely they are to forgo treatment, leading to more costly acute care.
http://catalyst.phrma.org/burden-on-patients-mental-health-disorders-can-affect-anyone-and-health-insurance-exchanges-must-pro

A critical opportunity to prevent prescription drug abuse

PhRMA  |  Blog Post

This is an opportunity to collectively work together to support ongoing educational efforts so the public, patients, caregivers and others understand the dangers of prescription drug abuse and the role they can play in reducing the potential for abuse and misuse.
http://catalyst.phrma.org/a-critical-opportunity-to-prevent-prescription-drug-abuse

Chart Pack: Value of Personalized Medicine

PhRMA  |  Report

This chart pack provides facts and figures about the promise of personalized medicine in delivering the right treatment to the right patient at the right dose the first time through the use of molecular biomarker tests and targeted therapies.
https://www.phrma.org/report/chart-pack-value-of-personalized-medicine

You have reviewed the first 150 results out of 2166. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next